LeonaBio, Inc. (LONA) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.4x

Market Cap

$71.42M

MomentumView details →

1D Return

−1.56%

YTD Return

−2.91%

RSI (14)

41.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.4x

Market Cap

$71.42M

RSI (14)

41.4

MomentumView details →

1D Return

−1.56%

YTD Return

−2.91%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−421.06%

ROA (TTM)

−248.63%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

+12.41%

Revenue CAGR 3Y

—

EPS CAGR 3Y

+1.98%

EBITDA YoY

+4.59%

EarningsView details →

EPS (Actual)

−$0.80

EPS Surprise

42.40%

Beats (12Q)

6/12

Next Q EPS Est

−$0.69

Avg Surprise (4Q)

−323.10%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

7.01x

Quick Ratio

7.01x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−141.46M

Op. CF (TTM)

−61.93M

Next earningsNov 5, 2026 →

Latest newsMore news →

LeonaBio reported its financial results for the second quarter of 2026 and provided a business update.21d ago

Similar companies

Nutriband Inc.NTRB Champions Oncology, Inc.CSBR Spero Therapeutics, Inc.SPRO Pliant Therapeutics, Inc.PLRX Tenax Therapeutics, Inc.TENX Cingulate Inc.CING Find similar companies →

Latest newsMore news →

LeonaBio reported its financial results for the second quarter of 2026 and provided a business update.21d ago